In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Panel Focuses On Quality Standards In Run-Up To Competitive Bidding

This article was originally published in The Gray Sheet

Executive Summary

As the deadline approaches for commencement of a competitive bidding program for medical products such as wheelchairs, walkers and oxygen tanks, stakeholders are focused on CMS' completion of updated quality standards guidelines

You may also be interested in...



DME Competitive Bidding Needs More Work, Time, Stakeholders Say

Durable medical equipment stakeholders suggest that CMS offer more detail in its competitive bidding proposal, and they maintain that the agency should issue its supplier quality standards before publishing a final competitive bidding regulation

DME Competitive Bidding Needs More Work, Time, Stakeholders Say

Durable medical equipment stakeholders suggest that CMS offer more detail in its competitive bidding proposal, and they maintain that the agency should issue its supplier quality standards before publishing a final competitive bidding regulation

DME Suppliers: Competitive Bidding Rebate Program Could Taint Industry

A CMS proposal to allow certain durable medical equipment suppliers to offer Medicare beneficiaries rebates on product purchases was roundly criticized by members of CMS' Program Advisory & Oversight Committee at a May 23 meeting in Baltimore

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023590

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel